Oxytocin Impurity 5 (Trifluoroacetate)
● Em Estoque
| Nº do catálogo: | VE0019412 |
|---|---|
| Nº CAS: | N/A |
| Fórmula Mol.:: | C43H65N11O13S2. C2HF3O2 |
| Peso Mol.:: | 1008.18 114.02 g/mol |
Informações adicionais sobre o Oxytocin Impurity 5 (Trifluoroacetate)
Fármaco de origem
OxytocinNome IUPAC
((4R, 7S, 10S, 13S, 16S, 19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6, 9, 12, 15, 18-pentaoxo-1, 2-dithia-5, 8, 11, 14, 17-pentaazacycloicosane-4-carbonyl)-L-prolyl-L-leucylglycine, trifluoroacetate (1:1)Sinônimos
N/ASMILES
O=C(O)CNC([C@H](CC(C)C)NC([C@H]1N(C([C@@H](NC([C@H](CC(N)=O)NC([C@H](CCC(N)=O)NC([C@H]([C@@H](C)CC)NC([C@H](CC2=CC=C(O)C=C2)N3)=O)=O)=O)=O)CSSC[C@H](N)C3=O)=O)CCC1)=O)=O.O=C(O)C(F)(F)FInChI
InChI=1S/C43H65N11O13S2.C2HF3O2/c1-5-22(4)35-42(66)48-26(12-13-32(45)56)38(62)50-29(17-33(46)57)39(63)52-30(20-69-68-19-25(44)36(60)49-28(40(64)53-35)16-23-8-10-24(55)11-9-23)43(67)54-14-6-7-31(54)41(65)51-27(15-21(2)3)37(61)47-18-34(58)59;3-2(4,5)1(6)7/h8-11,21-22,25-31,35,55H,5-7,12-20,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,61)(H,48,66)(H,49,60)(H,50,62)(H,51,65)(H,52,63)(H,53,64)(H,58,59);(H,6,7)/t22-,25-,26-,27-,28-,29-,30-,31-,35-;/m0./s1Descrição
The compound Oxytocin Impurity 5 (Trifluoroacetate) is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Oxytocin production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.
Solicitar orçamento
"*" indica campos obrigatórios



![D-[Asp]5-Oxytocin D-[Asp]5-Oxytocin](https://veeprho.com/wp-content/uploads/2025/08/VE0025172-D-Asp5-Oxytocin.png)





